Investment in Avidex Ltd
December 27 2000 - 9:03AM
UK Regulatory
RNS Number:3678W
Oxford Technology Vent Cap Tst PLC
22 December 2000
AVIDEX LTD
#25,000
Oxford Technology VCT has invested a further #25,000 for 625 ordinary shares in
Avidex Ltd.
The company is a spin out from the University of Oxford and is led by Dr
Jakobsen, who was head of the T Cell Receptor Group at the Institute of
Molecular Medicine. The company is working in two primary areas, the use of
engineered CD8 as an inhibitor of various auto-immune diseases such as
rheumatoid arthritis, and the use of engineered, soluble T Cell receptors to
target drugs. The company also has a novel drug screening technology.
For further information, please contact Oxford Technology VCT on 01865 784466.
Oxford Technology Ventur... (LSE:OXT)
Historical Stock Chart
From Jul 2024 to Jul 2024
Oxford Technology Ventur... (LSE:OXT)
Historical Stock Chart
From Jul 2023 to Jul 2024